Heron Therapeutics - Chart of the Day

Heron Therapeutics (HRTX) is the Barchart Chart of the Day.  The medical drug company has a Trend Spotter buy signal, a Weighted Alpha of 191.31+ and gained 276.57% in the last year.

The Chart of the Day is Heron Therapeutics (HRTX).  I found the medical drug stock by using Barchart to sort the Russell 3000 Index stocks first for the Barchart technical buy signals of 80% or better then for a positive Weighted Alpha.  Since the Trend Spotter signaled a buy on 8/11 the stock gained 16.76%.

Heron Therapeutics Inc. is a specialty pharmaceutical company. The company is developing products using its proprietary Biochronomer (TM) polymer-based drug delivery platform. Its product portfolio includes APF530, is being developed for the prevention of acute chemotherapy-induced nausea and vomiting. Heron Therapeutics Inc., formerly known as A.P. Pharma, Inc., is based in Redwood City, CA. The status of Barchart's Opinion trading systems are listed below.  Please note that the Barchart Opinion indicators are updated live during the session every 10 minutes and can therefore change during the day as the market fluctuates.  The indicator numbers shown below therefore may not match what you see live on the Barchart.com web site when you read this report. Barchart technical indicators: 100% Barchart technical buy signals 191.31+ Weighted Alpha Trend Spotter buy signal Above its 20, 30 and 100 day moving averages 3 new highs and up 9.47% in the last month Relative Strength Index 61.62% Barchart computes a technical support level at 32.81 Recently traded at 35.36 with a 50 day moving average of 32.14 Fundamental factors: Market Cap $1.22 billion Revenue estimates not given Earnings estimated to increase 1.40% this year, an additional 36.40% next year and continue to compound at an annual rate of 54.00% for the next 5 years Wall Street analysts issued 6 strong buy ratings on this stock The 20-100 Day MACD Oscillator has been a reliable technical trading strategy for this stock. Under current market condition I am making no buy recommendations.  This post is meant to show you that even in choppy markets like the present Barchart can assist you in finding stocks trading against the tape.